Posted by Michael Wonder on 25 Mar 2026
ICER launches program to accelerate the consideration of value into drug development programs
25 March 2026 - ICER will leverage its health technology assessment expertise to encourage better evidence development in clinical trial programs.
The ICER today formally launched ICER’s Scientific Advice, a new offering to advise companies on evidence generation strategies that will support a more comprehensive assessment of clinical effectiveness and value.
